Andrew Phillips, Nexo Therapeutics CEO
Scoop: Versant, NEA launch new biotech helmed by ex-CEO of protein degrader C4 Therapeutics
Long-time biotech venture firms Versant and New Enterprise Associates are backing a new startup run by former C4 Therapeutics chief executive Andrew Phillips. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
